Topics
-
ANTITRUST
-
Asset Management
-
Data, Privacy & Cybersecurity
-
Digital Health
-
Employee Benefits/ERISA
-
Enforcement
-
False Claims Act
-
FDA REGULATORY
- Health Care
-
Intellectual Property
-
PRIVATE EQUITY
-
TAX
Capital Insights
Analysis
- Lummis-Gillibrand Digital Asset Bill – Key Takeaways
(June 17, 2022) - Russia/Ukraine Crisis: U.S. Sanctions Escalation Continues
(May 9, 2022) - Russia/Ukraine Crisis: U.S. Imposes Significant New Sanctions in Response to Russian Atrocities in Ukraine
(April 8, 2022) - Podcast - Talkin' Trade: Enforcement of Section 337 Exclusion Orders at U.S. Customs and Border Protection
(April 7, 2022) - Podcast - Non-binding Guidance: Real-World Evidence in Drug Development
(March 30, 2022)
In The News
- In Modern Healthcare, Margaux Hall Discusses FTC Investigation of Pharmacy Benefit Managers
(June 16, 2022) - In Technology Transfer Tactics Health Care Attorneys Analyze HHS Opinion Clarifying Anti-Kickback Rules for Physician Inventors
(May 19, 2022) - In Law360, Attorneys Examine CMS Changes Coming to Medicare Part D Market
(May 18, 2022) - Chambers Cybersecurity 2022 USA Chapter Authored by Ed McNicholas, Fran Faircloth and Kevin Angle
(April 8, 2022) - In Bloomberg Law, Scott McKeown Examines Confirmation of New USPTO Director
(April 8, 2022)